Multidisciplinary Approach for Poor Prognosis Sinonasal Tumors in Operable Patients

NCT02099175 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

41

Enrollment

OTHER

Sponsor class

Conditions

Sinonasal Tumors

Interventions

DRUG: Cisplatin
DRUG: Docetaxel
DRUG: 5-fluorouracil
DRUG: Etoposide
DRUG: Adriamycin
DRUG: Ifosfamide
DRUG: Leucovorin
RADIATION: Radiotherapy - Patients needing Elective Nodal Volume (ENI)
RADIATION: Radiotherapy - Patients not needing ENI
RADIATION: Radiotherapy - Patients needing curative neck irradiation

Sponsor

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

Collaborators

[object Object]